204 related articles for article (PubMed ID: 26648098)
1. Theaflavin-3, 3'-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways, not via MAPK pathways.
Gao Y; Rankin GO; Tu Y; Chen YC
Int J Oncol; 2016 Jan; 48(1):281-92. PubMed ID: 26648098
[TBL] [Abstract][Full Text] [Related]
2. Theaflavin-3,3'-Digallate Suppresses Human Ovarian Carcinoma OVCAR-3 Cells by Regulating the Checkpoint Kinase 2 and p27 kip1 Pathways.
Gao Y; Yin J; Tu Y; Chen YC
Molecules; 2019 Feb; 24(4):. PubMed ID: 30769778
[TBL] [Abstract][Full Text] [Related]
3. The epigallocatechin gallate derivative Y
Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of (-)-epigallocatechin-3-gallate and theaflavin-3-3'-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways.
Gao Y; Li W; Jia L; Li B; Chen YC; Tu Y
Biochem Biophys Res Commun; 2013 Aug; 438(2):370-4. PubMed ID: 23892041
[TBL] [Abstract][Full Text] [Related]
5. Theaflavin-3, 3'-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells.
Tu Y; Kim E; Gao Y; Rankin GO; Li B; Chen YC
Int J Oncol; 2016 Jun; 48(6):2657-65. PubMed ID: 27082635
[TBL] [Abstract][Full Text] [Related]
6. Theasaponin E
Li B; Tong T; Ren N; Rankin GO; Rojanasakul Y; Tu Y; Chen YC
Molecules; 2021 Mar; 26(6):. PubMed ID: 33802884
[TBL] [Abstract][Full Text] [Related]
7. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
He L; Zhang E; Shi J; Li X; Zhou K; Zhang Q; Le AD; Tang X
Cancer Chemother Pharmacol; 2013 Mar; 71(3):713-25. PubMed ID: 23292117
[TBL] [Abstract][Full Text] [Related]
8. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells.
Gao N; Nester RA; Sarkar MA
Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414
[TBL] [Abstract][Full Text] [Related]
9. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
10. GABARBP down-regulates HIF-1α expression through the VEGFR-2 and PI3K/mTOR/4E-BP1 pathways.
Park SH; Kim BR; Lee JH; Park ST; Lee SH; Dong SM; Rho SB
Cell Signal; 2014 Jul; 26(7):1506-13. PubMed ID: 24686084
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory Effects of the Four Main Theaflavin Derivatives Found in Black Tea on Ovarian Cancer Cells.
Gao Y; Rankin GO; Tu Y; Chen YC
Anticancer Res; 2016 Feb; 36(2):643-51. PubMed ID: 26851019
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of black tea pigments, theaflavin‑3/3'-gallate against cisplatin-resistant ovarian cancer cells by inducing apoptosis and G1 cell cycle arrest.
Pan H; Wang F; Rankin GO; Rojanasakul Y; Tu Y; Chen YC
Int J Oncol; 2017 Nov; 51(5):1508-1520. PubMed ID: 29048667
[TBL] [Abstract][Full Text] [Related]
13. Suppression of VEGF expression through interruption of the HIF‑1α and Akt signaling cascade modulates the anti‑angiogenic activity of DAPK in ovarian carcinoma cells.
Park ST; Kim BR; Park SH; Lee JH; Lee EJ; Lee SH; Rho SB
Oncol Rep; 2014 Feb; 31(2):1021-9. PubMed ID: 24337450
[TBL] [Abstract][Full Text] [Related]
14. Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells.
Zhang Q; Tang X; Lu Q; Zhang Z; Rao J; Le AD
Mol Cancer Ther; 2006 May; 5(5):1227-38. PubMed ID: 16731755
[TBL] [Abstract][Full Text] [Related]
15. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.
Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate and theaflavin-3, 3'-digallate synergistically restore the balance between apoptosis and autophagy in synovial fibroblast of RA: an ex vivo approach with cultured human RA FLS.
Misra S; Bagchi A; Sarkar A; Niyogi S; Bhattacharjee D; Chatterjee S; Mondal S; Chattopadhyay A; Saha A; Chatterjee S; Sinhamahapatra P; Chakrabarti P; Chatterjee M; Ghosh A
Inflammopharmacology; 2021 Oct; 29(5):1427-1442. PubMed ID: 34350509
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of catechin- and theaflavin-mediated cardioprotection.
Dreger H; Lorenz M; Kehrer A; Baumann G; Stangl K; Stangl V
Exp Biol Med (Maywood); 2008 Apr; 233(4):427-33. PubMed ID: 18367631
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3-gallate inhibits nicotine-induced migration and invasion by the suppression of angiogenesis and epithelial-mesenchymal transition in non-small cell lung cancer cells.
Shi J; Liu F; Zhang W; Liu X; Lin B; Tang X
Oncol Rep; 2015 Jun; 33(6):2972-80. PubMed ID: 25845434
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of xanthine oxidase and suppression of intracellular reactive oxygen species in HL-60 cells by theaflavin-3,3'-digallate, (-)-epigallocatechin-3-gallate, and propyl gallate.
Lin JK; Chen PC; Ho CT; Lin-Shiau SY
J Agric Food Chem; 2000 Jul; 48(7):2736-43. PubMed ID: 10898615
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway.
Li G; Shan C; Liu L; Zhou T; Zhou J; Hu X; Chen Y; Cui H; Gao N
PLoS One; 2015; 10(2):e0117440. PubMed ID: 25659153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
